250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 5 Beauty Startup Investors in Switzerland in September 2025

A list of 5 angel investors and VC (Venture Capital) funds that invest in Beauty startups based in Switzerland. We rank investors based on the number of investments they made in Beauty companies from Switzerland. We update this investor list every month.

Top 5 Beauty Startup Investors in Switzerland in September 2025

Investor Beauty Switzerland investments
Ertan Wittwer 2
Yellowstone Holding 1
Giammaria Giuliani 1
Zürcher Kantonal Bank 1
UZH Life Sciences Fund 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Ertan Wittwer Angel · Munich, Bayern, Germany
Ertan Wittwer is the Founder and Board Member bestsmile. He attended BBZ Uzwil.
Show more
Investment focus
  • Health Care, Water, Beauty
  • Seed, Angel, Pre-Seed
  • Switzerland, United States
Portfolio highlights
  • Noriware — Noriware wants to revolutionize the packaging industry by offering a truly sustainable, home-compostable alternative to traditional plastic, through unlocking the potential of seaweed. In doing so, we want to be the leader in transparency to motivate the industry to become more sustainable.
  • Alpine White — Alpine White is a healthcare startup that manufactures personal care products and treatments for its consumers. They exist to keep teeth healthy and white through great products and services that empower people to feel confident and feel good.
  • Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.
Yellowstone Holding VC Fund · Versoix, Geneve, Switzerland
Yellowstone Holding promoting new innovative products or technologies from Switzerland to the Asia market via our strong connections.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B, Series C
  • Switzerland, Taiwan, Germany
Portfolio highlights
  • Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
  • CryoTherapeutics — USING CRYOTHERAPY TO TREAT AND PREVENT HEART ATTACKS
  • ZuriMED Technologies AG — Revolutionizing Soft Tissue Repair in Sports Medicine through Innovative Technologies
Giammaria Giuliani Angel
Giammaria Giuliani
Show more
Investment focus
  • Beauty, Cosmetics
  • Series A, Series B
  • Switzerland
Portfolio highlights
  • Cutiss — CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns.
Zürcher Kantonal Bank VC Fund · Zürich, Zurich, Switzerland · 13 investments in the past 12 months
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Series A, Funding Round
  • Switzerland, Japan, Spain
Portfolio highlights
  • askEarth — We are your experts in satellite imagery (Earth Observation) and large language models (LLMs)
  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
  • Polypeptide Group — The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service.The Group is one of the world’s largest independent contract manufacturers of therapeutic peptides forthe cosmetic, pharmaceutical and veterinary markets employing more than 450 people in six manufacturing sites located in France, India, Scandinavia and the USA.PolyPeptide Group is privately-held organization that manufactures over one third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.
UZH Life Sciences Fund VC Fund · Zürich, Zurich, Switzerland
The UZH Life Sciences Fund involves two equal partners: the UZH Foundation and the Novartis Venture Fund. It seeks donations from private individuals, foundations and companies for the strategic priorities of the University of Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Funding Round, Seed, Convertible Note
  • Switzerland
Portfolio highlights
  • Occlufit — Occlufit is an occluder device that conforms to complex geometries and provides immediate sealing of cardiovascular defects.
  • Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Investors by industry
Investors by country
Investors in Switzerland by industry